title: Fingolimod-induced atrioventricular conduction defects in a young lady with multiple sclerosis--insights into possible drug mechanism.
authors.affiliation: St. Vincent's University Hospital, Elm Park, Dublin 4, Ireland, victor.voon@gmail.com.
authors.forename: Victor
authors.initials: V
authors.lastname: Voon
authors.forename: Lavanya
authors.initials: L
authors.lastname: Saiva
authors.forename: Sara
authors.initials: S
authors.lastname: O'Kelly
authors.forename: David
authors.initials: D
authors.lastname: Keane
mesh_terms: D000284:Administration, Oral; D054537:Atrioventricular Block / Q000139:chemically induced* / Q000503:physiopathology; D005260:Female; D000068876:Fingolimod Hydrochloride; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*; D011409:Propylene Glycols / Q000009:adverse effects* / Q000627:therapeutic use; D013110:Sphingosine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D055815:Young Adult
chemical_list: D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine